Our results offer 'proof of concept' for the future use of a pharmaceutical senolytic strategy to reduce the risk of ...

A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...

A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...

The Joint Clinical Research Centre (JCRC) at Lubowa in partnership with Asea BioTherapeutics (ABT) today successfully treated their first client with cutting-edge stem cell therapy, marking a historic ...

Uganda has treated its first patient using advanced stem cell therapy, marking a ground-breaking milestone in East Africa's medical history.Stem cell therapy, also known as regenerative medicine, uses ...